Related Experiment Video
Updated: May 17, 2026

12:21
Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram
Published on: November 27, 2016
The serotonin transporter gene and depression.
Depression and Anxiety
|October 31, 2012
Summary
Genetic studies suggest depression is influenced by many common gene variants, not solely the serotonin transporter gene. Large-scale genome approaches offer more reliable insights into depression
Area of Science:
- Psychiatric genetics
- Neuroscience
- Genomics
Background:
- Depression exhibits genetic influence, yet specific contributing variants are largely unidentified.
- The serotonin transporter gene (5-HTTLPR) has been extensively studied for its role in depression and antidepressant response, but findings are inconsistent.
- Previous research on gene x environment interactions and amygdala activation in depression has yielded limited replicability.
Purpose of the Study:
- To critically evaluate the role of the serotonin transporter gene in depression.
- To explore the insights provided by whole genome approaches in understanding the genetic architecture of depression.
- To reconcile conflicting findings regarding specific gene associations with depression.
Main Methods:
- Review of existing literature on genetic associations with depression, including single-locus and gene x environment interaction studies.
- Analysis of findings from whole genome association studies (WGAS) for common diseases.
- Comparison of results from candidate gene studies with those from WGAS.
Main Results:
- The serotonin transporter gene likely plays a minor role in depression, contrary to earlier hypotheses.
- Whole genome approaches reveal that depression's genetic architecture involves numerous common variants with small effects.
- A potential contribution from a smaller number of rare variants with larger effects is also suggested by WGAS.
Conclusions:
- The serotonin transporter gene is unlikely to be a major determinant of depression.
- Future research should prioritize findings from whole genome methods to guide single-locus analyses.
- Understanding depression genetics requires acknowledging the polygenic nature of the disorder.
Related Concept Videos
G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
Depressive Disorders: Etiology
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

